Aarti Drugs Q4 Results: Profit Jumps 33%

The margin narrowed to 13.8% in the quarter ended March.

Aarti Drugs Ltd. consolidated net profit grew 33% in the fourth quarter of the last financial year (Image: company website)

Aarti Drugs Ltd. consolidated net profit grew 33% in the fourth quarter of the last financial year.

The pharmaceutical company posted a profit of Rs 63 crore in the quarter ended March, according to an exchange filing on Tuesday.

Aarti Drugs Q4 FY25 Highlights (Consolidated, YoY)

  • Revenue up 9% to Rs 676 crore versus Rs 620 crore.

  • Ebitda up 8% to Rs 93.2 crore versus Rs 86.1 crore.

  • Margin narrows to 13.8% versus 13.9%.

  • Net profit up 33% to Rs 63 crore versus Rs 47.4 crore.

Also Read: HPCL Q4 Results: Net Profit Rises 11%; Final Dividend Declared

Shares of Aarti Drugs closed 1.45% lower at Rs 349.9 apiece on the National Stock Exchange before the results were announced, compared to a 0.33% decline in the benchmark Nifty.

Also Read: Q4 Results: Mahanagar Gas Earnings Meet Estimates; BSE Profit More Than Doubles; NSE Earnings Down

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
WRITTEN BY
Ann Jacob
Ann Jacob tracks markets with a special focus on personal finance. She clos... more
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google
Google Badge